Global Oncology & Cancer Drugs Market Status and Forecast 2021-2027
Report Code: KNJ942995 No. of Pages: 181 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Oncology & Cancer Drugs market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Oncology & Cancer Drugs industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.
According to this survey, the global Oncology & Cancer Drugs market is estimated to have reached $ million in 2020, and projected to grow at a CAGR of % to $ million by 2027.
Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Oncology & Cancer Drugs Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Oncology & Cancer Drugs market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.
The Global Oncology & Cancer Drugs Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Oncology & Cancer Drugs industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions
Segmented by Type
Chemotherapy
Targeted Therapy
Segmented by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Others
Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia
Key manufacturers included in this survey
Sanofi
Roche
Pfizer
Otsuka
Novartis
Merck KGaA
Merck & Co.
Johnson & Johnson
Ipsen
Gilead Sciences
Eli Lilly
Eisai
Celgene
Bristol-Myers Squibb
Biogen Idec
Bayer
AstraZeneca
Astellas
Amgen
AbbVie
Table of Contents
1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Oncology & Cancer Drugs Market Status and Forecast (2016-2027)
1.3.2 Global Oncology & Cancer Drugs Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Oncology & Cancer Drugs Supply by Company
2.1 Global Oncology & Cancer Drugs Sales Volume by Company
2.2 Global Oncology & Cancer Drugs Sales Value by Company
2.3 Global Oncology & Cancer Drugs Price by Company
2.4 Oncology & Cancer Drugs Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Oncology & Cancer Drugs Market Status by Type
3.1 Oncology & Cancer Drugs Type Introduction
3.1.1 Chemotherapy
3.1.2 Targeted Therapy
3.1.3 Immunotherapy (Biologic Therapy)
3.1.4 Hormonal Therapy
3.1.5 Others
3.2 Global Oncology & Cancer Drugs Market by Type
3.2.1 Global Oncology & Cancer Drugs Sales Volume by Type (2016-2021)
3.2.2 Global Oncology & Cancer Drugs Sales Value by Type (2016-2021)
3.2.3 Global Oncology & Cancer Drugs Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Oncology & Cancer Drugs Market Status by Application
4.1 Oncology & Cancer Drugs Segment by Application
4.1.1 Blood Cancer
4.1.2 Breast Cancer
4.1.3 Gastrointestinal Cancer
4.1.4 Prostate Cancer
4.1.5 Respiratory/Lung Cancer
4.1.6 Others
4.2 Global Oncology & Cancer Drugs Market by Application
4.2.1 Global Oncology & Cancer Drugs Sales Volume by Application (2016-2021)
4.2.2 Global Oncology & Cancer Drugs Sales Value by Application (2016-2021)
4.2.3 Global Oncology & Cancer Drugs Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Oncology & Cancer Drugs Market Status by Region
5.1 Global Oncology & Cancer Drugs Market by Region
5.1.1 Global Oncology & Cancer Drugs Sales Volume by Region
5.1.2 Global Oncology & Cancer Drugs Sales Value by Region
5.2 North America Oncology & Cancer Drugs Market Status
5.3 Europe Oncology & Cancer Drugs Market Status
5.4 Asia Pacific Oncology & Cancer Drugs Market Status
5.5 Central & South America Oncology & Cancer Drugs Market Status
5.6 Middle East & Africa Oncology & Cancer Drugs Market Status
6 North America Oncology & Cancer Drugs Market Status
6.1 North America Oncology & Cancer Drugs Market by Country
6.1.1 North America Oncology & Cancer Drugs Sales Volume by Country (2016-2021)
6.1.2 North America Oncology & Cancer Drugs Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Oncology & Cancer Drugs Market Status
7.1 Europe Oncology & Cancer Drugs Market by Country
7.1.1 Europe Oncology & Cancer Drugs Sales Volume by Country (2016-2021)
7.1.2 Europe Oncology & Cancer Drugs Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Oncology & Cancer Drugs Market Status
8.1 Asia Pacific Oncology & Cancer Drugs Market by Country
8.1.1 Asia Pacific Oncology & Cancer Drugs Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Oncology & Cancer Drugs Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Oncology & Cancer Drugs Market Status
9.1 Central & South America Oncology & Cancer Drugs Market by Country
9.1.1 Central & South America Oncology & Cancer Drugs Sales Volume by Country (2016-2021)
9.1.2 Central & South America Oncology & Cancer Drugs Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Oncology & Cancer Drugs Market Status
10.1 Middle East & Africa Oncology & Cancer Drugs Market by Country
10.1.1 Middle East & Africa Oncology & Cancer Drugs Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Oncology & Cancer Drugs Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Oncology & Cancer Drugs Manufacturing Cost Analysis
11.5 Oncology & Cancer Drugs Sales Channel and Distributors Analysis
11.5.1 Oncology & Cancer Drugs Sales Channel
11.5.2 Oncology & Cancer Drugs Distributors
11.6 Oncology & Cancer Drugs Downstream Major Buyers
12 Global Oncology & Cancer Drugs Market Forecast by Type and by Application
12.1 Global Oncology & Cancer Drugs Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Oncology & Cancer Drugs Forecast by Type
12.2.1 Global Oncology & Cancer Drugs Sales Volume Forecast by Type
12.2.2 Global Oncology & Cancer Drugs Sales Value Forecast by Type
12.2.3 Global Oncology & Cancer Drugs Price Forecast by Type
12.3 Global Oncology & Cancer Drugs Forecast by Application
12.3.1 Global Oncology & Cancer Drugs Sales Volume Forecast by Application
12.3.2 Global Oncology & Cancer Drugs Sales Value Forecast by Application
12.3.3 Global Oncology & Cancer Drugs Price Forecast by Application
13 Global Oncology & Cancer Drugs Market Forecast by Region/Country
13.1 Global Oncology & Cancer Drugs Market Forecast by Region (2022-2027)
13.1.1 Global Oncology & Cancer Drugs Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Oncology & Cancer Drugs Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Teva
14.1.1 Company Information
14.1.2 Oncology & Cancer Drugs Product Introduction
14.1.3 Teva
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Takeda
14.2.1 Company Information
14.2.2 Oncology & Cancer Drugs Product Introduction
14.2.3 Takeda
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Sanofi
14.3.1 Company Information
14.3.2 Oncology & Cancer Drugs Product Introduction
14.3.3 Sanofi
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Roche
14.4.1 Company Information
14.4.2 Oncology & Cancer Drugs Product Introduction
14.4.3 Roche
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Pfizer
14.5.1 Company Information
14.5.2 Oncology & Cancer Drugs Product Introduction
14.5.3 Pfizer
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 Otsuka
14.6.1 Company Information
14.6.2 Oncology & Cancer Drugs Product Introduction
14.6.3 Otsuka
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Novartis
14.7.1 Company Information
14.7.2 Oncology & Cancer Drugs Product Introduction
14.7.3 Novartis
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Merck KGaA
14.8.1 Company Information
14.8.2 Oncology & Cancer Drugs Product Introduction
14.8.3 Merck KGaA
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
14.9 Merck & Co.
14.9.1 Company Information
14.9.2 Oncology & Cancer Drugs Product Introduction
14.9.3 Merck & Co.
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.9.4 SWOT Analysis
14.10 Johnson & Johnson
14.10.1 Company Information
14.10.2 Oncology & Cancer Drugs Product Introduction
14.10.3 Johnson & Johnson
Oncology & Cancer Drugs Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.10.4 SWOT Analysis
14.11 Ipsen
14.12 Gilead Sciences
14.13 Eli Lilly
14.14 Eisai
14.15 Celgene
14.16 Bristol-Myers Squibb
14.17 Biogen Idec
14.18 Bayer
14.19 AstraZeneca
14.20 Astellas
14.21 Amgen
14.22 AbbVie
15 Conclusion
16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com